Gilead held the 6th Advanced Therapies Meeting to celebrate therapeutic advances in the treatment of lymphoma. consalud.es Advanced therapies are transforming the way we understand and […]

Madrid launches a pioneering strategy to become a global benchmark in biopharmaceutical innovation. consalud.es On Monday, the Community of Madrid presented its 2025-2028 Sector Strategy to […]

This “fast track” is one of the sector’s strategic measures in the field of biomedical research and is included in the National Pharmaceutical Industry Strategy. Patients […]

At a time of great challenges in global health research, one of the countries with the most influence in this field is preparing a national strategy […]

A recent study by the Centre for Cell Therapy (CTC) reveals proteins and signalling pathways that are crucial to the effectiveness of CAR-T cells, opening up […]

The director of the ISCIII, Marina Pollán, and the president of Farmaindustria, Fina Lladós, have signed a General Action Protocol to promote research, innovation and knowledge […]

The Pharmaceutical R&D Survey 2024 reflects a steady increase in investment in clinical research over the last decade, which has grown at 7% per year. Direct […]

The XVIII Conference of Biomedical Research Technology Platforms brings together in Madrid more than 200 representatives from public administrations, regulatory agencies, universities and companies to analyse […]

Nathalie Moll (EFPIA) warns in an interview with Health35 that the lack of regulatory consistency and proposed environmental changes threaten investment in biomedical R&D in Europe. […]

In order to host the studies, the centres must have the resources and infrastructure. Gregorio Marañón, La Paz, Clínic de Barcelona and Vall d’Hebron are some […]

Farmaindustria presents improvements to the Draft Medicines Bill to prepare healthcare for innovation in the next 20 yearsThe future law should promote greater investment in healthcare, […]

“It is essential to see medicines and healthcare as an economically and socially very profitable investment for Spain. An investment that generates very important benefits in […]

eleconomista.es In 2023, Spain overtook Germany as the country that initiated the most clinical trials and became the European leader. This is reflected in the report […]

Joint position on the Draft Bill on Medicines and Health ProductsThe proposed system of price regulation for off-patent medicines puts at risk the supply of medicines […]

The International Federation of Innovative Pharmaceutical Industries indicates that the sector invests almost 30% of its revenues in R&D, amounting to nearly 270 billion euros. Diarofarma.com […]

The Regional Minister of Health of Cantabria, César Pascual, inaugurates the 25th CAAC-Pharmaindustry Forum. ‘When we work together, not only do we promote research and biomedical […]

This research momentum means that one in three new medicines approved by Europe in 2024 was classified as an orphan drug. There are still many untreated […]

Getting to know new markets and establishing contacts with both potential customers and potential suppliers. Temperature control in pharmaceutical logistics is one of our pillars, as […]

The President of the Government meets for the second time with around twenty representatives of the national, European and global pharmaceutical industry to intensify public-private collaboration […]

For the first time, a study by the consultancy firm Afi has evaluated the impact of pharmaceutical companies from a dual perspective: the socio-economic value provided […]

37% of all clinical trials being developed in Spain are aimed at treating oncological diseases New drugs are having a direct impact on patient survival, according […]

More than 80 pupils from five schools learn about the process of getting medicines to patients: from R&D to clinical trials The “Bringing science to schools” […]

The European Medicines Agency approved a total of 114 medicines last year, 46 of which had a new active substance, seven more than the previous year. […]

The Coordination Committee of the Technological Platform for Innovative Medicines defines its action plan for 2025 Madrid will host the 18th Annual Conference of Biomedical Research […]

Our country is the leader in Europe with 930 clinical studies authorised in 2024. 22% of research to find new drugs is aimed at rare diseases […]

The Aemps authorised a total of 930 studies last year, making it the European regulatory agency that approved the most clinical trials, ahead of countries such […]

The International Federation of Innovative Pharmaceutical Industry publishes the Facts & Figures 2024 report, which outlines the industry’s contribution globally. In 2023, the industry filed 12,425 […]

Pipeline Innovation Review, carried out by the consultancy firm Iqvia for the European Federation of the Pharmaceutical Industry (Efpia) and Vaccines Europe, covers biomedical research underway […]

Farmaindustria and Levante-EMV hold a meeting with experts to discuss the creation of the ‘ICAP Guide’ of good practices for the promotion of clinical research in […]

The trial, which will evaluate a vaccine under clinical investigation by GSK, will be conducted in Phase I units at La Paz, La Princesa and Puerta […]